Product Information

CARVEDILOL 3.125 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0168 per EA under NDC 00904730561. Its NADAC has been published 100 times since Sep 25, 2024.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL 3.125 MG TABLET

Carvedilol
$0.0168per EA

Strength

3.125 mg/1

NDC

00904730561

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA078251

FDA Approved

9/5/2007

TE Code

AB

On Market Since

7/1/2024

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 3.125 MG TABLET has been published 100 times since Sep 25, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0168 per EA
All-time high$0.0174 (Jun 10, 2026)
All-time low$0.0133 (Nov 20, 2024)
52-week high$0.0174
52-week low$0.0163
Median price$0.0169
Average price$0.0166
Largest weekly change-22.2% (Nov 20, 2024)
Weeks tracked100
Tracking sinceSep 25, 2024

Price History

1W

+0.2%

1M

+0.2%

3M

-3.8%

6M

-0.6%

1Y

+0.1%

3Y

N/A

5Y

N/A

All

-1.4%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARVEDILOL 3.125 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 3.125 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0168 per EA (NDC 00904730561), effective Aug 19, 2026.

How has the price of CARVEDILOL 3.125 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 3.125 MG TABLET has held within roughly two percent of its current level. It has been tracked across 100 weekly CMS publications since Sep 25, 2024.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 3.125 MG TABLET?

Since Sep 25, 2024, the NADAC for CARVEDILOL 3.125 MG TABLET has ranged from a low of $0.0133 (Nov 20, 2024) to a high of $0.0174 (Jun 10, 2026), with a median of $0.0169 per EA.

Are there cheaper alternatives to CARVEDILOL 3.125 MG TABLET?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 3.125 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 3.125 MG TABLET?

CARVEDILOL 3.125 MG TABLET (NDC 00904730561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.